Structural Heart Program
Emory Healthcare offers a comprehensive cross functional Structural Heart program - a one-stop institution for valve treatment, from medical management to traditional surgical care as well as access to the latest cutting edge research. We perform structural heart procedures, such as Transcatheter Aortic Valve Replacement (TAVR), at Emory University Hospital, Emory University Hospital Midtown and Saint Joseph’s Hospital.
Emory is on the cutting edge of work in structural heart. Emory Healthcare was one of the first programs in the nation to offer Transcatheter Aortic Valve Replacements as a part of the PARTNER I trial. Our physician and structural heart team were instrumental in the Edwards Saipan device receiving FDA approval in 2012 and have completed over 460 TAVR procedures to date. Further, Emory Healthcare physicians will start work on 5 new trials in efforts to develop even newer treatment options for patients with aortic stenosis.
Some of the conditions the Structural Heart team treats are:
• Valve Disorders including stenosis (narrowing) or regurgitation (leakage) of the aortic valve, the mitral valve, the pulmonary valve and the tricuspid valve.
• Structural Heart Defects including atrial septal defects (ASD), ventricular septal defects, patent foramen ovales and paravalvular leaks.
Multidisciplinary Structural Heart Team
The Emory Healthcare structural heart team is composed of physicians and healthcare providers from many cross functional heart and vascular areas including, interventional cardiology and cardiothoracic surgery and cardiac imaging. These physicians work together to provide innovative heart treatment solutions and the best possible outcomes for our patients with structural heart diseases. A sample of the procedures the group performs are:
• Transcatheter aortic valve replacement
• Balloon valvuloplasty
• Minimally invasive mitral valve repair
• Septal defect and patent foramen ovale closure
• Left atrial appendage (LAA) closure
